Australia markets open in 49 minutes

Benitec Biopharma Inc. (BNTC)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.3501+0.0143 (+4.26%)
At close: 04:00PM EDT
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/06/2022
30/06/2021
30/06/2020
30/06/2019
Total revenue
73
73
59
97
11,317
Cost of revenue
9
9
123
-185
426.5064
Gross profit
64
64
-64
282
10,890
Operating expenses
Research development
11,272
11,272
7,020
3,001
2,174
Selling general and administrative
6,646
6,646
6,512
5,567
6,659
Total operating expenses
17,918
17,918
13,532
8,563
8,352
Operating income or loss
-17,854
-17,854
-13,596
-8,281
2,538
Interest expense
32
32
-
-
-
Total other income/expenses net
-322
-322
-280
-55
210.1017
Income before tax
-18,208
-18,208
-13,882
-8,274
2,867
Income tax expense
-
-
-
-
0
Income from continuing operations
-18,208
-18,208
-13,882
-8,274
2,867
Net income
-18,208
-18,208
-13,882
-8,274
2,867
Net income available to common shareholders
-18,208
-18,208
-13,882
-8,274
2,867
Basic EPS
-
-2.23
-3.23
-8.10
3.34
Diluted EPS
-
-2.23
-3.23
-8.10
3.34
Basic average shares
-
8,172
4,295
1,021
858.281
Diluted average shares
-
8,172
4,295
1,021
858.281
EBITDA
-
-17,784
-13,172
-7,907
2,693